Published in Hospital Business Week, August 5th, 2007
Under the terms of the agreement, Akorn will be responsible for development, marketing and distribution. Haemonetics will manufacture the three products at its intravenous solutions manufacturing facility in Union, SC. The products are all expected to launch between 2010 and 2011, and represent a current total U.S. market size of approximately $500 million. One of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week